[go: up one dir, main page]

DK0595924T3 - Antagonister for blodpladeaktiverende faktorer - Google Patents

Antagonister for blodpladeaktiverende faktorer

Info

Publication number
DK0595924T3
DK0595924T3 DK92915895T DK92915895T DK0595924T3 DK 0595924 T3 DK0595924 T3 DK 0595924T3 DK 92915895 T DK92915895 T DK 92915895T DK 92915895 T DK92915895 T DK 92915895T DK 0595924 T3 DK0595924 T3 DK 0595924T3
Authority
DK
Denmark
Prior art keywords
pct
pyrrolo
pyridin
carbonyl
paf
Prior art date
Application number
DK92915895T
Other languages
English (en)
Inventor
James B Summers
Steven K Davidsen
James H Holms
Daisy Pireh
H Robin Heyman
Michael B Martin
Douglas H Steinman
George S Sheppard
George M Carrera Jr
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of DK0595924T3 publication Critical patent/DK0595924T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/69Two or more oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Radiology & Medical Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK92915895T 1991-07-17 1992-07-14 Antagonister for blodpladeaktiverende faktorer DK0595924T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73168191A 1991-07-17 1991-07-17
PCT/US1992/005890 WO1993001813A1 (en) 1991-07-17 1992-07-14 Platelet activating factor antagonists

Publications (1)

Publication Number Publication Date
DK0595924T3 true DK0595924T3 (da) 1999-11-01

Family

ID=24940541

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92915895T DK0595924T3 (da) 1991-07-17 1992-07-14 Antagonister for blodpladeaktiverende faktorer

Country Status (15)

Country Link
US (1) US5459152A (da)
EP (1) EP0595924B1 (da)
JP (1) JP3135917B2 (da)
KR (1) KR100251603B1 (da)
AT (1) ATE178796T1 (da)
AU (1) AU651243B2 (da)
CA (1) CA2112562A1 (da)
DE (1) DE69228932T2 (da)
DK (1) DK0595924T3 (da)
ES (1) ES2131530T3 (da)
GR (1) GR3030208T3 (da)
IE (1) IE922293A1 (da)
IL (1) IL102494A0 (da)
PT (1) PT100698B (da)
WO (1) WO1993001813A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486525A (en) * 1993-12-16 1996-01-23 Abbott Laboratories Platelet activating factor antagonists: imidazopyridine indoles
US5567711A (en) * 1995-04-19 1996-10-22 Abbott Laboratories Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
US6630496B1 (en) 1996-08-26 2003-10-07 Genetics Institute Llc Inhibitors of phospholipase enzymes
US6916841B2 (en) * 1998-02-25 2005-07-12 Genetics Institute, Llc Inhibitors of phospholipase enzymes
US6828344B1 (en) 1998-02-25 2004-12-07 Genetics Institute, Llc Inhibitors of phospholipase enzymes
US6500853B1 (en) 1998-02-28 2002-12-31 Genetics Institute, Llc Inhibitors of phospholipase enzymes
AU6762400A (en) * 1999-08-12 2001-03-13 Cor Therapeutics, Inc. Inhibitors of factor xa
DE10004157A1 (de) * 2000-02-01 2001-08-02 Merckle Gmbh Chem Pharm Fabrik 4-Pyridyl-und 2,4-Pyrimidinyl-substituierte Pyrrolderivate und ihre Anwendung in der Pharmazie
WO2011100359A1 (en) * 2010-02-09 2011-08-18 Ironwood Pharmaceuticals, Inc. Cannabinoid agonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2541280B1 (fr) * 1983-01-13 1985-06-21 Rhone Poulenc Sante Nouveaux derives du 1h, 3h-pyrrolo (1,2c) thiazolecarboxamide-7, leur preparation et les medicaments qui les contiennent
FR2617484B1 (fr) * 1987-07-02 1989-10-20 Rhone Poulenc Sante Procede de preparation de l'acide (pyridyl-3)-3 1h-3h-pyrrolo (1,2-c) thiazolecarboxylique-7 dextrogyre
FR2626004B1 (fr) * 1988-01-20 1991-08-02 Rhone Poulenc Sante Procede de preparation du (pyridyl-3)-3 1h, 3h-pyrrolo (1,2-c) thiazolecarbonitrile-7
JP3061631B2 (ja) * 1989-10-11 2000-07-10 山之内製薬株式会社 新規なヘテロ環化合物およびその製造法

Also Published As

Publication number Publication date
ATE178796T1 (de) 1999-04-15
AU651243B2 (en) 1994-07-14
EP0595924B1 (en) 1999-04-14
ES2131530T3 (es) 1999-08-01
PT100698A (pt) 1993-10-29
JP3135917B2 (ja) 2001-02-19
CA2112562A1 (en) 1993-02-04
DE69228932T2 (de) 1999-11-11
GR3030208T3 (en) 1999-08-31
AU2339192A (en) 1993-02-23
EP0595924A1 (en) 1994-05-11
US5459152A (en) 1995-10-17
PT100698B (pt) 1999-07-30
IL102494A0 (en) 1993-01-14
DE69228932D1 (de) 1999-05-20
JPH06510027A (ja) 1994-11-10
EP0595924A4 (en) 1994-08-24
KR100251603B1 (ko) 2000-05-01
WO1993001813A1 (en) 1993-02-04
IE922293A1 (en) 1993-01-27

Similar Documents

Publication Publication Date Title
IL111963A0 (en) Platelet activating factor antagonists: imidazopyridine indoles
AU5429596A (en) Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
IL93508A0 (en) Novel benzimidazole and azabenimidazole derivatives,their methods of preparation,synthesis intermediates and pharmaceutical compositions in which they are present and which are useful especially for the treatment of cardiovascular diseases and duodenal ulcers
FI20115753L (fi) Farmaseuttisia koostumuksia IL-6:n tuoton aiheuttamien sairauksien hoitoon
DK0595924T3 (da) Antagonister for blodpladeaktiverende faktorer
ATE214929T1 (de) Verwendung von 7-(2-oxa-5,8-diazabicyclo 4.3.0)non-8-yl)-chinoloncarbonsäure- und - naphthyridoncarbonsäure-derivaten zur herstellung eines arzneimittels zur therapie von helicobacter-pylori-infektionen und den damit assoziierten gastroduodenalen erkrankungen
NO172575C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzocykloalkanderivater
DE69923467D1 (de) 2,3-disubstituierte pyridinderivate, verfahren zur derren herstellung, sie enthaltende wirkstoffzubereitungen und zwischenprodukte für die herstellung
NO902710D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive r(-) 3-kinuklidinol-derivater.
MY105555A (en) Heterocyclicguanidines as 5ht 3 antagonists.
DE69514532D1 (de) Indol-2,3-dione-3-oximderivate, ihre herstellung und verwendung
DE59106334D1 (de) Giessmasse zur Herstellung keramischer Grünfolien und ihre Verwendung.
HUT55003A (en) Process for producing acyl derivatives of hydroxy-pyrimidines
FI910816L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 3H-6H-1,4,5a,8a,-tetra-atsa-asenaftyleeni-3,5(4H)-dionijohdannaisten valmistamiseksi
DE69429447D1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 7 infektionen
EP0122155A3 (en) Improvements in or relating to naphthylglycyl cephalosporin derivatives
FI913656A7 (fi) Menetelmä alkyyli-6-pyridatsiinijohdannaisten valmistamiseksi
ITMI941939A0 (it) Derivati purinici ed 8-azapurinici atti al trattamento terapeutico dell'aids
FI954169A0 (fi) Menetelmä 3-substituoitujen 2-oksoindolijohdannaisten valmistamiseksi
ATE216995T1 (de) Kristalline mupirocinpolymorphe
ES2009363A6 (es) Procedimiento de preparacion de nuevos derivados de octahidro-indenofurano.
PL288352A1 (en) Method of obtaining bisindole alkaloids exhibiting cytostatic effect
IT1244725B (it) 1-b-ribofuranosil-pirazol-derivati e relativo processo di produzione e impiego farmacologico
IT8321417A0 (it) Procedimento per preparare derivati dell'1-(fenil)-1-idrossi-2-ammino-3-fluoro-propano e loro intermedi.
NO171451C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenetanolamin-derivater